Photronics (PLAB) to Post Q4 Earnings: What's in the Offing?
https://www.zacks.com/stock/news/2196907/photronics-plab-to-post-q4-earnings-what-s-in-the-offing?cid=CS-ZC-FT-analyst_blog|earnings_preview-2196907
Dec 12, 2023 - Photronics' (PLAB) fiscal fourth-quarter results are likely to reflect sluggishness in the semiconductor end market.
0
Guess? (GES) Hurt by Soft Americas Retail Unit & Cost Woes
https://www.zacks.com/stock/news/2196905/guess-ges-hurt-by-soft-americas-retail-unit-cost-woes?cid=CS-ZC-FT-analyst_blog|rank_focused-2196905
Dec 12, 2023 - Guess? (GES) is witnessing weakness across its Americas retail business amid a dynamic macroeconomic environment. Rising operating costs are major concerns.
0
Unlocking Q1 Potential of Costco (COST): Exploring Wall Street Estimates for Key Metrics
https://www.zacks.com/stock/news/2196334/unlocking-q1-potential-of-costco-cost-exploring-wall-street-estimates-for-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm_preview-2196334
Dec 11, 2023 - Get a deeper insight into the potential performance of Costco (COST) for the quarter ended November 2023 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
0
Big Week for Fed FOMC and Key Inflation Data
https://www.zacks.com/stock/news/2196251/big-week-for-fed-fomc-and-key-inflation-data?cid=CS-ZC-FT-economic_highlights-2196251
Dec 11, 2023 - Big Week for Fed FOMC and Key Inflation Data.
0
Beat the Market the Zacks Way: Shopify, Lululemon, Telos in Focus
https://www.zacks.com/stock/news/2195999/beat-the-market-the-zacks-way-shopify-lululemon-telos-in-focus?cid=CS-ZC-FT-analyst_blog|investment_ideas-2195999
Dec 11, 2023 - Our time-tested methodologies were at work to help investors navigate the market well last week. Here are some of our key performance data from the past three months.
0
3 Medicare Gotchas That Could Cost You a Fortune
https://www.fool.com/retirement/2023/12/10/3-medicare-gotchas-that-could-cost-you-a-fortune/?source=iedfolrf0000001
Dec 10, 2023 - You might spend a lot more under Medicare than expected. Consider yourself warned,
0
Solid Balance Sheet Aids PNC Financial (PNC), High Costs Ail
https://www.zacks.com/stock/news/2195729/solid-balance-sheet-aids-pnc-financial-pnc-high-costs-ail?cid=CS-ZC-FT-analyst_blog|company_news_-_finance_sector-2195729
Dec 08, 2023 - PNC Financials' (PNC) solid balance sheet and strategic initiatives will continue supporting its financials. However, a rise in costs will hurt.
0
Adobe (ADBE) to Post Q4 Earnings: What's in the Offing?
https://www.zacks.com/stock/news/2195710/adobe-adbe-to-post-q4-earnings-what-s-in-the-offing?cid=CS-ZC-FT-analyst_blog|earnings_preview-2195710
Dec 08, 2023 - Adobe's (ADBE) fiscal Q4 performance is likely to reflect strength across the Digital Media and Digital Experience businesses.
0
Effective Pricing Actions Aid B&G Foods (BGS) Amid High Costs
https://www.zacks.com/stock/news/2195639/effective-pricing-actions-aid-b-g-foods-bgs-amid-high-costs?cid=CS-ZC-FT-analyst_blog|rank_focused-2195639
Dec 08, 2023 - B&G Foods (BGS) is reaping benefits from continued margin recovery on the back of pricing actions undertaken to counter inflationary costs through pricing and productivity efforts.
0
bluebird bio gene therapy lovo-cel for sickle cell disease has $3.1M cost (updated)
https://seekingalpha.com/news/4044803-bluebird-bio-gains-fda-approval-gene-therapy-lovo-cell-sickle-cell-disease?source=feed_sector_healthcare
Dec 08, 2023 - The FDA approves bluebird bio's gene therapy for sickle cell disease, boosting shares by 7%. Read more here.
0